Condition: Calcitonin · Subcutaneous · Acute Herpes Zoster · Sponsor: Tanta University
This prospective randomized controlled study will be conducted to evaluate the effect of adding calcitonin to the standard treatment protocol in patients with acute herpes zoster infection.
This description comes directly from the study's public registry record.
Amira M Elkeblawy, MD · 01148529429 · marmoramero999@gmail.com
Always discuss trial participation with your own doctor first.
| Tanta University Hospitals | Tanta, Gharbia Governorate, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07655804